Dr. Douglas R. Adkins
Claim this profileWashington University School of Medicine
Expert in Squamous Cell Carcinoma
Expert in Skin Cancer
37 reported clinical trials
64 drugs studied
Area of expertise
1Squamous Cell Carcinoma
Global LeaderStage IV
Stage III
PD-L1 positive
2Skin Cancer
Global LeaderStage IV
Stage III
p16 positive
Affiliated Hospitals
Clinical Trials Douglas R. Adkins is currently running
Trastuzumab Emtansine
for Salivary Gland Cancer
This phase II trial tests whether ado-trastuzumab emtansine works to shrink tumors in patients with HER2-positive salivary gland cancer that has come back (recurrent), spread to other places in the body (metastatic), or cannot be removed by surgery (unresectable). Trastuzumab emtansine is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug called emtansine. Trastuzumab attaches to HER2 positive cancer cells in a targeted way and delivers emtansine to kill them. Trastuzumab emtansine may work better compared to usual treatment of chemotherapy with docetaxel and trastuzumab in treating patients with salivary gland cancer.
Recruiting1 award Phase 2
Ramucirumab + Pembrolizumab
for Head and Neck Cancer
This is a phase 2 study investigating the efficacy of ramucirumab in combination with pembrolizumab compared to pembrolizumab monotherapy. Ramucirumab is a VEGFR-2 inhibitor believed to potentially enhance the efficacy of PD-1 inhibitors such as pembrolizumab.
Recruiting1 award Phase 217 criteria
More about Douglas R. Adkins
Clinical Trial Related1 year of experience running clinical trials · Led 37 trials as a Principal Investigator · 18 Active Clinical TrialsTreatments Douglas R. Adkins has experience with
- Pembrolizumab
- Cisplatin
- Cetuximab
- Surgery
- Intensity-Modulated Radiation Therapy
- Carboplatin
Breakdown of trials Douglas R. Adkins has run
Squamous Cell Carcinoma
Skin Cancer
Head and Neck Squamous Cell Carcinoma
Neck Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Douglas R. Adkins specialize in?
Douglas R. Adkins focuses on Squamous Cell Carcinoma and Skin Cancer. In particular, much of their work with Squamous Cell Carcinoma has involved Stage IV patients, or patients who are Stage III.
Is Douglas R. Adkins currently recruiting for clinical trials?
Yes, Douglas R. Adkins is currently recruiting for 17 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Douglas R. Adkins has studied deeply?
Yes, Douglas R. Adkins has studied treatments such as Pembrolizumab, Cisplatin, Cetuximab.
What is the best way to schedule an appointment with Douglas R. Adkins?
Apply for one of the trials that Douglas R. Adkins is conducting.
What is the office address of Douglas R. Adkins?
The office of Douglas R. Adkins is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.